Pricing Strategy

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

The ventures arm of a top-20 U.S. health system sought support developing a go-to-market strategy for RWD-augmented biobank offerings